Orion - Changes in company's own shares

Orion Corporation: Transfer of 102,900 own B-shares

Orion Corporation       Stock Exchange Release   1 March 2011      at 6.45 p.m.
EET


In accordance with a decision by the Board of Directors, Orion Corporation has
on 1 March 2011 transferred altogether 102,900 Orion Corporation B-shares held
by the company as a share reward for 2010 to the persons employed by the Orion
Group and belonging to the Share-based Incentive Plan of the Orion Group. The
transfer is based on the authorisation by the Annual General Meeting of 24 March
2010. The price per share of the transferred shares is EUR 16.7488, which is the
volume weighted average quotation of the Orion Corporation B-share on 1 March
2011. Accordingly, the total transaction price of the transferred shares is EUR
1,723,451.52.

After the share transfer, the total number of own B-shares held by Orion
Corporation is 413,754.

Orion Corporation has informed about the Share-based Incentive Plan in a stock
exchange release on 18 February 2010.


Orion Corporation

Timo Lappalainen                   Olli Huotari
President and CEO                 SVP, Corporate Functions




Publisher:
Orion Corporation
Communications
Orionintie 1A, 02200 Espoo
Homepage: www.orion.fi


Orion is an innovative European R&D-based pharmaceutical and diagnostic company
with a special emphasis on developing medicinal treatments and diagnostic tests
for global markets. Orion develops, manufactures and markets human and
veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic
tests. Orion's pharmaceutical R&D focuses on the following core therapy areas:
central nervous system drugs, cancer and critical care drugs, and Easyhaler(®)
pulmonary drugs.

The Group's net sales in 2010 amounted to approximately EUR 850 million. The
Company invested EUR 85 million in research and development. At the end of
2010, the Group had a total of approximately 3,100 employees, of whom 2,450
worked in Finland and 650 in other European countries. Orion's A and B shares
are listed on NASDAQ OMX Helsinki.

[HUG#1493559]